Johns Hopkins Aramco Healthcare opens Oncology Centre of Excellence

Johns Hopkins Aramco Healthcare (JHAH) has announced the opening of its Oncology Center of Excellence in Saudi Arabia.

Serving patients across the GCC, the centre combines Johns Hopkins Medicine’s world-class oncology expertise with the kingdom’s advanced healthcare infrastructure, offering personalised solutions to address the region’s unique needs.

With cancer cases in the GCC projected to increase by over 140 per cent between 2020 and 2040, the centre addresses the urgent need for advanced, specialised oncology care.

Oncology Center of Excellence specialisation

Specialising in breast, colorectal, and prostate cancers — three of the most prevalent cancers in the GCC — the Oncology Center of Excellence provides a comprehensive approach to cancer care.

Its offerings include early detection, precision diagnostics, advanced treatments, and survivorship programmes, establishing a holistic and patient-centred model of care.

With evidence-based protocols, advanced technologies, and a multidisciplinary team of specialists, the facility serves as a pillar of global excellence for oncology care originating from the GCC.

Strong partnership with Johns Hopkins Medicine

Michael Walsh, CEO of JHAH, said, “The launch of the Oncology Center of Excellence marks a pivotal moment in our partnership with Johns Hopkins Medicine, demonstrating our shared commitment to advancing healthcare in Saudi Arabia and the wider GCC. By integrating Johns Hopkins Medicine’s globally recognised expertise with Saudi Arabia’s cutting-edge healthcare infrastructure, we are responding to the region’s oncology challenges while setting a new global standard for cancer care.”

“This centre is a testament to the power of international collaboration in transforming healthcare delivery. By implementing evidence-based protocols and utilising cutting-edge technologies developed by Johns Hopkins Medicine in the US, we are ensuring that patients across the GCC have access to world-class cancer care.”

“This milestone reinforces our mission to provide innovative, patient-focused solutions and strengthens the GCC’s position as a hub for global medical excellence,” he added.